Huang Michael F.
Sr. VP of Clinical Development at SOLENO THERAPEUTICS INC
- Sold, on record
- $1.2M
- Dollars the filings state
- Form 4 sales
- 2
- Latest Mar 27, 2026
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- SOLENO THERAPEUTICS INCSr. VP of Clinical Development
Sales by reason
0
Routine
0
Plan not stated
1
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice SOLENO THERAPEUTICS INCNoticeMar 27, 2025 2025
Filed to sell 29,625 shares ($1.5M)
Huang Michael F., Officer
No 10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale SOLENO THERAPEUTICS INCUnusualMar 27, 2025 same day
Sold 14,583 shares at $69.51 ($1M)
Huang Michael F., Sr. VP of Clinical Development
No 10b5-1 planSold 28.4% of holdings ($3.6M position)36,817 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 4 sale SOLENO THERAPEUTICS INCNo planMar 27, 2026 +365 days
Sold 6,582 shares at $30.44 ($200k)
Huang Michael F., Sr. VP of Clinical Development
No 10b5-1 planSold 14.2% of holdings ($1.4M position)39,823 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 27, 2026 | Mar 31, 2026 | SOLENO THERAPEUTICS INC | Sr. VP of Clinical Development | Form 4 sale | 6,582 | $200k | 14.2% | No plan | SEC |
| Mar 27, 2025 | Mar 31, 2025 | SOLENO THERAPEUTICS INC | Sr. VP of Clinical Development | Form 4 sale | 14,583 | $1M | 28.4% | Unusual | SEC |
| Mar 27, 2025 | Mar 27, 2025 | SOLENO THERAPEUTICS INC | Officer | Form 144 notice | 29,625 | $1.5M | Notice | SEC |